Serum Uric Acid Level and Its Relationship to Non-Motor Symptomatology in Parkinson’s disease
Objective: To determine the relationship between serum uric acid level and non-motor symptoms using the PD specific non-motor symptoms in Nigerian patients with Parkinson’s disease.…FuRST2.0: Development of a modified functional rating scale for use in premanifest and early-manifest Huntington’s disease
Objective: Develop a patient-reported outcome (PRO) modification of the Functional Rating Scale for pre-Huntington Disease (FuRST-pHD) using focus group, Delphi panel and cognitive pre-testing methodology.…Relationship between non-motor symptom symptoms and clinical symptoms in Parkinson’s disease using “Non-Motor Symptom assessment scale for Parkinson’s disease”
Objective: We evaluated the relationship between non-motor symptoms and clinical signs in patients with Parkinson’s disease (PD). Background: Patients with Parkinson's disease (PD) manifest not…Annual Clinical Evaluation in Out Patient Clinic May Improve Quality of Life in Patients with Parkinson’s Disease
Objective: The aim of this study was to examine whether the annual clinical evaluation system improves QOL in Parkinson’s disease (PD) patients. Background: We perform…Study of prevalence of non-motor symptoms in typical and atypical parkinsonism as compared to age and sex matched healthy controls
Objective: 1) To study prevalence and clinical characteristics of non-motor symptoms (NMS) in idiopathic parkinson disease (IPD) and atypical Parkinsonism (APD) as compared to age…Degeneration of vagus nerve but not of accessory and phrenic nerve in Parkinson’s disease revealed by high-resolution ultrasound
Objective: To test the hypothesis that the vagus nerve is measurably atrophic in idiopathic Parkinson’s disease (PD). Background: The vagus nerve is discussed to represent…Validation of the Parkinson’s Disease Pain Symptoms Scale (PD-PSS): An interim report
Objective: To explore the psychometric properties of the PD-PSS. Background: Evaluating pain in PD patients can be a difficult issue in the everyday clinical practice.…Levodopa effect on non-motor symptoms in late stage Parkinson’s disease
Objective: To assess responsiveness of non-motor symptoms (NMS) to Levodopa (L-dopa) and to describe the NMS burden in late stage Parkinson's disease (PD). Moreover, to…Factors affecting quality of life in patients with Parkinson´s disease: Motor vs non-motor symptoms. Results from the COPPADIS Study Cohort
Objective: To identify factors related to a worse health-related and global perceived quality of life (QoL) in a cohort of Parkinson´s disease (PD) patients and…The Prevalence of Gastrointestinal Symptoms in Parkinson’s Disease Patients in Bethesda Hospital, Yogyakarta, Indonesia
Objective: We were conducting the research to determine the prevalence of the gastrointestinal symptoms in Parkinson's disease patients in Bethesda Hospital, Yogyakarta, Indonesia, by using…
- « Previous Page
- 1
- …
- 33
- 34
- 35
- 36
- 37
- …
- 51
- Next Page »